|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.04 USD | +5.75% |
|
+4.96% | +28.09% |
| 07-09 | US lawmakers renew concerns about GenScript's ties to China | RE |
| 07-07 | RBC Lowers Price Target on Legend Biotech to $75 From $78, Keeps Outperform Rating | MT |
EPS & Dividend: Legend Biotech Corporation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -2.56 | -2.74 | -2.8 | -2.94 | -0.96 | -0.8736 | 0.4334 | 1.056 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 28.16 | 46.61 | 49.92 | 60.17 | 32.54 | 39.75 | 39.75 | 39.75 |
| Nbr of stocks (in thousands) | 132,638 | 153,946 | 167,403 | 181,789 | 183,451 | 184,288 | - | - |
| Announcement Date | 18/03/21 | 18/03/22 | 30/03/23 | 11/03/24 | 11/03/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: Legend Biotech Corporation
| 28/08/2025 | Q2 2025 Earnings Release (Projected) |
| 23/11/2025 | Q3 2025 Earnings Release (Projected) |
| 17/03/2026 | Q4 2025 Earnings Release (Projected) |
| 18/05/2026 | Q1 2026 Earnings Release (Projected) |
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | -45.5x | 7.38x | 6.6x | ||
| -.--% | -.--% | 49.61x | 5.42x | 8.53x | ||
| 1.52% | 1.72% | 18.99x | 3.37x | 4.74x | ||
| -.--% | -.--% | -23.89x | 1.29x | 5.93x | ||
| -.--% | -.--% | -66.37x | - | - | ||
| -.--% | -.--% | -19.64x | 58.12x | 43.76x | ||
| -.--% | -.--% | 1188.59x | 15.01x | 29.12x | ||
| -.--% | -.--% | 25.79x | 2.15x | 4.53x | ||
| -.--% | -.--% | 13.78x | 2.16x | 2.73x | ||
| -.--% | -.--% | 19.46x | 4.38x | 4.69x | ||
| Average | 0.15% | 0.17% | 116.08x | 11.03x | 12.29x | |
| Weighted average by Cap. | 0.24% | 0.28% | 88.92x | 10.66x | 12.01x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition